257 related articles for article (PubMed ID: 26271611)
21. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
[TBL] [Abstract][Full Text] [Related]
22. Ki67 Heterogeneity in Estrogen Receptor-Positive Breast Cancers: Which Tumor Type Has the Most Heterogeneity?
Himuro T; Horimoto Y; Arakawa A; Tanabe M; Saito M
Int J Surg Pathol; 2016 Apr; 24(2):103-7. PubMed ID: 26353854
[TBL] [Abstract][Full Text] [Related]
23. Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.
Stålhammar G; Robertson S; Wedlund L; Lippert M; Rantalainen M; Bergh J; Hartman J
Histopathology; 2018 May; 72(6):974-989. PubMed ID: 29220095
[TBL] [Abstract][Full Text] [Related]
24. Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
Horii R; Tsuda H; Masuda S; Sugita H; Togashi K; Ohno S; Akiyama F
Breast Cancer; 2020 Nov; 27(6):1058-1064. PubMed ID: 32440959
[TBL] [Abstract][Full Text] [Related]
25. Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.
Arihiro K; Oda M; Ohara M; Kadoya T; Osaki A; Nishisaka T; Shiroma N; Kobayashi Y
Jpn J Clin Oncol; 2016 Dec; 46(12):1081-1087. PubMed ID: 27511992
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract][Full Text] [Related]
28. Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging.
Hida AI; Omanovic D; Pedersen L; Oshiro Y; Ogura T; Nomura T; Kurebayashi J; Kanomata N; Moriya T
Histopathology; 2020 Sep; 77(3):471-480. PubMed ID: 32578891
[TBL] [Abstract][Full Text] [Related]
29. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists.
Morioka T; Niikura N; Kumaki N; Masuda S; Iwamoto T; Yokoyama K; Ogiya R; Oshitanai R; Terao M; Tsuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
Breast Cancer; 2018 Nov; 25(6):768-777. PubMed ID: 29959636
[TBL] [Abstract][Full Text] [Related]
31. Interlaboratory variability of Ki67 staining in breast cancer.
Focke CM; Bürger H; van Diest PJ; Finsterbusch K; Gläser D; Korsching E; Decker T;
Eur J Cancer; 2017 Oct; 84():219-227. PubMed ID: 28829990
[TBL] [Abstract][Full Text] [Related]
32. New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas.
Grala B; Markiewicz T; Kozłowski W; Osowski S; Słodkowska J; Papierz W
Folia Histochem Cytobiol; 2009; 47(4):587-92. PubMed ID: 20430724
[TBL] [Abstract][Full Text] [Related]
33. Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies.
Fasanella S; Leonardi E; Cantaloni C; Eccher C; Bazzanella I; Aldovini D; Bragantini E; Morelli L; Cuorvo LV; Ferro A; Gasperetti F; Berlanda G; Dalla Palma P; Barbareschi M
Diagn Pathol; 2011 Mar; 6 Suppl 1(Suppl 1):S7. PubMed ID: 21489202
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours.
Focke CM; Decker T; van Diest PJ
Histopathology; 2016 Nov; 69(5):849-861. PubMed ID: 27270560
[TBL] [Abstract][Full Text] [Related]
35. An adaptive positivity thresholding method for automated Ki67 hotspot detection (AKHoD) in breast cancer biopsies.
Pilutti D; Della Mea V; Pegolo E; La Marra F; Antoniazzi F; Di Loreto C
Comput Med Imaging Graph; 2017 Nov; 61():28-34. PubMed ID: 28499621
[TBL] [Abstract][Full Text] [Related]
36. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable.
Morimoto M; Bando Y; Nakagawa M; Takechi H; Yoshida T; Honda J; Tadokoro Y; Moriya T; Sasa M; Tangoku A
Breast Cancer; 2016 Jul; 23(4):577-82. PubMed ID: 25808597
[TBL] [Abstract][Full Text] [Related]
38. Good staining quality ensuring the reproducibility of Ki67 assessment.
Wang YH; Lai CR; Lien HC; Hsu CY
J Clin Pathol; 2020 Jul; 73(7):413-417. PubMed ID: 31796636
[TBL] [Abstract][Full Text] [Related]
39. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B
Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664
[TBL] [Abstract][Full Text] [Related]
40. Variability in measuring the Ki-67 labeling index in patients with breast cancer.
Yamamoto S; Chishima T; Mastubara Y; Adachi S; Harada F; Toda Y; Arioka H; Hasegawa N; Kakuta Y; Sakamaki K
Clin Breast Cancer; 2015 Feb; 15(1):e35-9. PubMed ID: 25445422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]